SelectScience releases editorial article, ‘Automated cell counting drives development of novel therapeutics’ featuring the LUNA-FX7™

Leading independent science publisher SelectScience® has released an editorial article entitled, ‘Automated cell counting drives development of novel therapeutics’, written by Cameron Smith-Craig, Pharma & Applied Sciences Editor, SelectScience® highlighting the LUNA-FX7™ automated cell counter.

The article explores the research efforts of Dr. Min Kyung Kang, Associate Researcher, AA12 Team, Initiative Antibody Group for Prestige Biopharma IDC. Dr. Kang’s research focuses on developing therapeutic strategies utilizing a broad range of cell-based assays to monitor and assess cellular behavior.

In the article, Dr. Kang discusses how the LUNA-FX7™ aautomated cell counter has played an integral role in her day-to-day research outlining different applications and uses. The advanced quality control and bioprocessing features are also described as a major factor for success in her research and discovery efforts.

Prestige Biopharma operates a regional R&D hub called the Innovative Discovery Center in South Korea with its headquarters located in Singapore.IDC

The full article can be accessed on the SelectScience® website by clicking here.